Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07073898 · ClinicalTrials.gov registry record · NA
UG3 Pilot Clinical Trial
A NA study of Lung Cancer, sponsored by University of Utah.
- Active
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT07073898: Active NA study of Lung Cancer, sponsored by University of Utah.
NCT07073898 is a NA study of Lung Cancer that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 65 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07073898, a NA study of Lung Cancer, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
LungSMART Utah utilizes a Population Health Management (PHM) approach that addresses key barriers to Lung Cancer Screening (LCS) implementation by deploying a centralized Hub infrastructure for eligibility assessment, individualized risk assessment and Shared Decision Making (SDM), LCS referral, and screening completion assistance, thereby increasing LCS reach at scale among Community Health Centers (CHCs) patients across the state of Utah.
Primary Outcome
This outcome measure will report the proportion of enrolled subjects who engaged with Lung Cancer Screening (LCS) text messages during the study period. LCS Engagement will be defined as any documented interaction with the text messaging system, as recorded by the study platform.
Conditions Studied
Interventions
- OTHER Educational Video
- OTHER Repeated Text Messages (TM+)
- OTHER Conversational Agent (CA)
- OTHER Proactive Patient Navigation (PPN)
- OTHER Reactive Patient Navigation (RPN)
Study Locations (1)
Utah
- Huntsman Cancer Institute/ University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2025-09-26 |
| Est. Completion | 2026-02-27 |
| Phase | NA |
What the registry record for NCT07073898 still lists
NCT07073898 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which Educational Video is the first listed.
NCT07073898 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT07073898 about?
NCT07073898 is a clinical study titled "UG3 Pilot Clinical Trial". LungSMART Utah utilizes a Population Health Management (PHM) approach that addresses key barriers to Lung Cancer Screening (LCS) implementation by deploying a centralized Hub infrastructure for eligibility assessment, individualized risk assessment and Shared Decision Making (SDM), LCS referral, and...
What is the current status of trial NCT07073898?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2025-09-26. Estimated completion is 2026-02-27.
What conditions does trial NCT07073898 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT07073898?
The interventions under investigation include: Educational Video (OTHER), Repeated Text Messages (TM+) (OTHER), Conversational Agent (CA) (OTHER), Proactive Patient Navigation (PPN) (OTHER), Reactive Patient Navigation (RPN) (OTHER).
Who is sponsoring clinical trial NCT07073898?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07073898 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07073898's enrollment target sits among peer trials
65 234th of 409 higher than 175 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI